Study Demonstrates Efficacy of Pitavastatin in Elderly Patients
Represents important treatment option for more vulnerable populations
Study Demonstrates Efficacy of Pitavastatin in Elderly Patients Pitavastatin represents important treatment option for more vulnerable populations
BOSTON, June 16, 2009 - New data presented today showed that pitavastatin is an effective treatment for the management of dyslipidemia in elderly patients, with a similar safety and tolerability profile to low-dose pravastatin. The Phase III data were presented today by Kowa, at the XV International Symposium on Atherosclerosis in Boston.
“This study shows the effectiveness of pitavastatin to lower LDL [low-density lipoprotein] cholesterol in a group of elderly patients with primary hypercholesterolemia or combined dyslipidemia,” said Professor Steen Stender, M.D., Ph.D., Gentofte University Hospital, Denmark, and an investigator for the study.